FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124385005> ?p ?o ?g. }

• W3124385005 abstract "Abstract Background Myanmar commenced a lymphatic filariasis (LF) elimination programme in 2000. Whilst the country has made considerable progress since then, a number of districts have demonstrated persistent transmission after many rounds of mass drug administration (MDA). The causes of unsuccessful MDA have been examined elsewhere; however, there remains little information on the factors that contribute in Myanmar. Methods We conducted an analysis of factors associated with persistent infection, LF-related hydrocoele and MDA participation in an area with ongoing transmission in 2015. A cross-sectional household survey was undertaken in 24 villages across four townships of Mandalay Region. Participants were screened for circulating filarial antigen (CFA) using immunochromatographic tests and, if positive, for microfilaria by night-time thick blood slide. Individuals 15 year and older were assessed for filariasis morbidity (lymphoedema and, if male, hydrocoele) by ultrasound-assisted clinical examination. A pre-coded questionnaire was used to assess risk factors for LF and for non-participation (never taking MDA). Significant variables identified in univariate analyses were included in separate step-wise multivariate logistic regressions for each outcome. Results After adjustment for covariates and survey design, being CFA positive was significantly associated with age [odds ratio (OR) 1.03, 95% CI 1.01–1.06), per year], male gender (OR 3.14, 1.27–7.76), elevation (OR 0.96, 0.94–0.99, per metre) and the density of people per household room (OR 1.59, 1.31–1.92). LF-related hydrocoele was associated with age (OR 1.06, 1.03–1.09, per year) and residing in Amarapura Township (OR 8.93, 1.37–58.32). Never taking MDA was associated with male gender [OR 6.89 (2.13–22.28)] and age, particularly in females, with a significant interaction term. Overall, compared to those aged 30–44 years, the proportion never taking MDA was higher in all age groups (OR highest in those < 5 years and > 60 years, ranging from 3.37 to 12.82). Never taking MDA was also associated with residing in Amarapura township (OR 2.48, 1.15–5.31), moving to one’s current village from another (OR 2.62, 1.12–6.11) and ever having declined medication (OR 11.82, 4.25–32.91). Decreased likelihood of never taking MDA was associated with a higher proportion of household members being present during the last MDA round (OR 0.16, 0.03–0.74) and the number visits by the MDA programme (OR 0.69, 0.48–1.00). Conclusions These results contribute to the understanding of LF and MDA participation-related risk factors and will assist Myanmar to improve its elimination and morbidity management programmes. Graphical Abstract" @default.
• W3124385005 created "2021-02-01" @default.
• W3124385005 creator A5008736284 @default.
• W3124385005 creator A5034173530 @default.
• W3124385005 creator A5035164977 @default.
• W3124385005 creator A5053086298 @default.
• W3124385005 creator A5056031818 @default.
• W3124385005 creator A5060698914 @default.
• W3124385005 creator A5061685710 @default.
• W3124385005 creator A5073966797 @default.
• W3124385005 creator A5075301521 @default.
• W3124385005 creator A5087170702 @default.
• W3124385005 date "2021-01-22" @default.
• W3124385005 modified "2023-10-18" @default.
• W3124385005 title "Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar" @default.
• W3124385005 cites W1980051101 @default.
• W3124385005 cites W1988358693 @default.
• W3124385005 cites W1991891889 @default.
• W3124385005 cites W2018494267 @default.
• W3124385005 cites W2030997274 @default.
• W3124385005 cites W2046042492 @default.
• W3124385005 cites W2058827183 @default.
• W3124385005 cites W2072946609 @default.
• W3124385005 cites W2086660909 @default.
• W3124385005 cites W2101889053 @default.
• W3124385005 cites W2106774610 @default.
• W3124385005 cites W2118256986 @default.
• W3124385005 cites W2126926648 @default.
• W3124385005 cites W2137122473 @default.
• W3124385005 cites W2143687643 @default.
• W3124385005 cites W2160245319 @default.
• W3124385005 cites W2166058586 @default.
• W3124385005 cites W2172178873 @default.
• W3124385005 cites W2176786307 @default.
• W3124385005 cites W2563939709 @default.
• W3124385005 cites W2617671364 @default.
• W3124385005 cites W2739875591 @default.
• W3124385005 cites W2743045386 @default.
• W3124385005 cites W2800372387 @default.
• W3124385005 cites W2807702149 @default.
• W3124385005 cites W2901190035 @default.
• W3124385005 cites W2913814842 @default.
• W3124385005 cites W3011611414 @default.
• W3124385005 doi "https://doi.org/10.1186/s13071-021-04583-y" @default.
• W3124385005 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7821648" @default.
• W3124385005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33482891" @default.
• W3124385005 hasPublicationYear "2021" @default.
• W3124385005 type Work @default.
• W3124385005 sameAs 3124385005 @default.
• W3124385005 citedByCount "5" @default.
• W3124385005 countsByYear W31243850052022 @default.
• W3124385005 countsByYear W31243850052023 @default.
• W3124385005 crossrefType "journal-article" @default.
• W3124385005 hasAuthorship W3124385005A5008736284 @default.
• W3124385005 hasAuthorship W3124385005A5034173530 @default.
• W3124385005 hasAuthorship W3124385005A5035164977 @default.
• W3124385005 hasAuthorship W3124385005A5053086298 @default.
• W3124385005 hasAuthorship W3124385005A5056031818 @default.
• W3124385005 hasAuthorship W3124385005A5060698914 @default.
• W3124385005 hasAuthorship W3124385005A5061685710 @default.
• W3124385005 hasAuthorship W3124385005A5073966797 @default.
• W3124385005 hasAuthorship W3124385005A5075301521 @default.
• W3124385005 hasAuthorship W3124385005A5087170702 @default.
• W3124385005 hasBestOaLocation W31243850051 @default.
• W3124385005 hasConcept C119599485 @default.
• W3124385005 hasConcept C126322002 @default.
• W3124385005 hasConcept C127413603 @default.
• W3124385005 hasConcept C141071460 @default.
• W3124385005 hasConcept C142052008 @default.
• W3124385005 hasConcept C142724271 @default.
• W3124385005 hasConcept C144024400 @default.
• W3124385005 hasConcept C144301174 @default.
• W3124385005 hasConcept C149923435 @default.
• W3124385005 hasConcept C151956035 @default.
• W3124385005 hasConcept C156957248 @default.
• W3124385005 hasConcept C165901193 @default.
• W3124385005 hasConcept C185032368 @default.
• W3124385005 hasConcept C203014093 @default.
• W3124385005 hasConcept C2776158911 @default.
• W3124385005 hasConcept C2777065887 @default.
• W3124385005 hasConcept C2777411658 @default.
• W3124385005 hasConcept C2777629521 @default.
• W3124385005 hasConcept C2779359454 @default.
• W3124385005 hasConcept C2780133432 @default.
• W3124385005 hasConcept C2908647359 @default.
• W3124385005 hasConcept C38180746 @default.
• W3124385005 hasConcept C71924100 @default.
• W3124385005 hasConcept C761482 @default.
• W3124385005 hasConcept C99454951 @default.
• W3124385005 hasConceptScore W3124385005C119599485 @default.
• W3124385005 hasConceptScore W3124385005C126322002 @default.
• W3124385005 hasConceptScore W3124385005C127413603 @default.
• W3124385005 hasConceptScore W3124385005C141071460 @default.
• W3124385005 hasConceptScore W3124385005C142052008 @default.
• W3124385005 hasConceptScore W3124385005C142724271 @default.
• W3124385005 hasConceptScore W3124385005C144024400 @default.
• W3124385005 hasConceptScore W3124385005C144301174 @default.
• W3124385005 hasConceptScore W3124385005C149923435 @default.
• W3124385005 hasConceptScore W3124385005C151956035 @default.
• W3124385005 hasConceptScore W3124385005C156957248 @default.

• next